A new partnership with GlaxoSmithKline drew intense scrutiny from customers, reflecting eroding public trust in companies’ ability to protect private information.
A new partnership with GlaxoSmithKline drew intense scrutiny from customers, reflecting eroding public trust in companies’ ability to protect private information.